These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 7907731)

  • 1. Wheat peptide challenge in coeliac disease.
    Sturgess R; Day P; Ellis HJ; Lundin KE; Gjertsen HA; Kontakou M; Ciclitira PJ
    Lancet; 1994 Mar; 343(8900):758-61. PubMed ID: 7907731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An immunodominant DQ8 restricted gliadin peptide activates small intestinal immune response in in vitro cultured mucosa from HLA-DQ8 positive but not HLA-DQ8 negative coeliac patients.
    Mazzarella G; Maglio M; Paparo F; Nardone G; Stefanile R; Greco L; van de Wal Y; Kooy Y; Koning F; Auricchio S; Troncone R
    Gut; 2003 Jan; 52(1):57-62. PubMed ID: 12477760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterizing one of the DQ2 candidate epitopes in coeliac disease: A-gliadin 51-70 toxicity assessed using an organ culture system.
    Martucci S; Fraser JS; Biagi F; Corazza GR; Ciclitira PJ; Ellis HJ
    Eur J Gastroenterol Hepatol; 2003 Dec; 15(12):1293-8. PubMed ID: 14624152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine mRNA expression in the mucosa of treated coeliac patients after wheat peptide challenge.
    Kontakou M; Przemioslo RT; Sturgess RP; Limb GA; Ellis HJ; Day P; Ciclitira PJ
    Gut; 1995 Jul; 37(1):52-7. PubMed ID: 7672681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activities of A-gliadin-related synthetic peptides: damaging effect on the atrophic coeliac mucosa and activation of mucosal immune response in the treated coeliac mucosa.
    Maiuri L; Troncone R; Mayer M; Coletta S; Picarelli A; De Vincenzi M; Pavone V; Auricchio S
    Scand J Gastroenterol; 1996 Mar; 31(3):247-53. PubMed ID: 8833354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo gluten ingestion in coeliac disease.
    Ciclitira PJ; Ellis HJ
    Dig Dis; 1998; 16(6):337-40. PubMed ID: 10207218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coeliac disease: in vivo toxicity of the putative immunodominant epitope.
    Fraser JS; Engel W; Ellis HJ; Moodie SJ; Pollock EL; Wieser H; Ciclitira PJ
    Gut; 2003 Dec; 52(12):1698-702. PubMed ID: 14633945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gliadin specific, HLA DQ2-restricted T cells are commonly found in small intestinal biopsies from coeliac disease patients, but not from controls.
    Molberg O; Kett K; Scott H; Thorsby E; Sollid LM; Lundin KE
    Scand J Immunol; 1997 Sep; 46(3):103-9. PubMed ID: 9315123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small intestinal T cells of celiac disease patients recognize a natural pepsin fragment of gliadin.
    van de Wal Y; Kooy YM; van Veelen PA; Peña SA; Mearin LM; Molberg O; Lundin KE; Sollid LM; Mutis T; Benckhuijsen WE; Drijfhout JW; Koning F
    Proc Natl Acad Sci U S A; 1998 Aug; 95(17):10050-4. PubMed ID: 9707598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-gliadin antibody specificity for gluten-derived peptides toxic to coeliac patients.
    Devery JM; La Brooy JT; Krillis S; Davidson G; Skerritt JH
    Clin Exp Immunol; 1989 Jun; 76(3):384-90. PubMed ID: 2752594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local challenge of oral mucosa with gliadin in patients with coeliac disease.
    Lähteenoja H; Mäki M; Viander M; Toivanen A; Syrjänen S
    Clin Exp Immunol; 2000 Apr; 120(1):38-45. PubMed ID: 10759761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope.
    Anderson RP; Degano P; Godkin AJ; Jewell DP; Hill AV
    Nat Med; 2000 Mar; 6(3):337-42. PubMed ID: 10700238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A non-toxic analogue of a coeliac-activating gliadin peptide: a basis for immunomodulation?
    Biagi F; Ellis HJ; Parnell ND; Shidrawi RG; Thomas PD; O'Reilly N; Corazza GR; Ciclitira PJ
    Aliment Pharmacol Ther; 1999 Jul; 13(7):945-50. PubMed ID: 10383530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological changes in small bowel mucosa induced by gliadin sensitive T lymphocytes can be blocked by anti-interferon gamma antibody.
    Przemioslo RT; Lundin KE; Sollid LM; Nelufer J; Ciclitira PJ
    Gut; 1995 Jun; 36(6):874-9. PubMed ID: 7615276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients.
    Lundin KE; Scott H; Hansen T; Paulsen G; Halstensen TS; Fausa O; Thorsby E; Sollid LM
    J Exp Med; 1993 Jul; 178(1):187-96. PubMed ID: 8315377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of intestinal mucosal toxicity of Triticum monococcum in celiac disease patients.
    Pizzuti D; Buda A; D'Odorico A; D'Incà R; Chiarelli S; Curioni A; Martines D
    Scand J Gastroenterol; 2006 Nov; 41(11):1305-11. PubMed ID: 17060124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The toxicity of high molecular weight glutenin subunits of wheat to patients with coeliac disease.
    Dewar DH; Amato M; Ellis HJ; Pollock EL; Gonzalez-Cinca N; Wieser H; Ciclitira PJ
    Eur J Gastroenterol Hepatol; 2006 May; 18(5):483-91. PubMed ID: 16607142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gliadin specific, HLA DQ2-restricted T cells are commonly found in small intestinal biopsies from coeliac disease patients, but not from controls.
    Molberg O; Kett K; Scott H; Thorsby E; Sollid LM; Lundin KE
    Scand J Immunol; 1997 Jul; 46(1):103-8. PubMed ID: 9246215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human genome search in celiac disease: mutated gliadin T-cell-like epitope in two human proteins promotes T-cell activation.
    Kumar R; Eastwood AL; Brown ML; Laurie GW
    J Mol Biol; 2002 Jun; 319(3):593-602. PubMed ID: 12054857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease.
    Maiuri L; Ciacci C; Ricciardelli I; Vacca L; Raia V; Auricchio S; Picard J; Osman M; Quaratino S; Londei M
    Lancet; 2003 Jul; 362(9377):30-7. PubMed ID: 12853196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.